Cbl-b, a mammalian homolog of Cbl, consists of an Nterminal region (Cbl-b-N) highly homologous to oncogenic v-Cbl, a Ring ®nger, and a C-terminal region containing multiple proline-rich stretches and potential tyrosine phosphorylation sites. In the present study, we demonstrate that upon engagement of the T cell receptor (TCR), endogenous Cbl-b becomes rapidly tyrosinephosphorylated. In heterogeneous COS-1 cells, Cbl-b was phosphorylated on tyrosine residues by both Syk- 
Introduction
Engagement of the T cell receptor (TCR)/CD3 complex induces a rapid increase in the activities of two families of non-receptor protein tyrosine kinases (PTKs), i.e., the Src (Fyn and Lck), and Syk (Syk and Zap-70) families (Wange and Samelson, 1996; Weiss and Littman, 1994) . The activated PTKs in turn induce the tyrosine phosphorylation of multiple intracellular proteins, eventually leading to T cell activation, lymphokine production, and proliferation. One of the recently identi®ed PTK substrates is Cbl, a 120 kDa product of c-cbl (Casitas B-lineage lymphoma) protooncogene, which was originally isolated as a cellular homolog of v-cbl, a part of the transforming gene of the Cas NS-1 murine leukemia retrovirus (Blake et al., 1991; Langdon et al., 1989) . Cbl is rapidly phosphorylated on tyrosine residues in response to stimulation of various cell surface receptors including the TCR (reviewed in Liu and Altman, 1998) , suggesting a critical role for Cbl in signal transduction pathways. The importance of Cbl in intracellular signal transduction is further emphasized by the observation that it associates with several other signaling molecules including the constitutive interaction with Grb2, the phosphotyrosine [Tyr(P)]-dependent interaction with phosphatidylinositol 3-kinase (PI3-K), Crk-L and Vav, and the phosphoserine-dependent interaction with 14-3-3 (reviewed in Liu and Altman, 1998) . Besides, Cbl associates with several PTKs including Zap-70 and Syk, and the interaction is mediated by the N-terminal phosphotyrosine-binding (PTB) domain of Cbl and the N(D)PY motifs in Zap-70 (Lupher et al., 1997) and Syk . These ®ndings suggest that Cbl complex(es) plays a critical role in the regulation of TCR-mediated downstream events during T cell activation. In this regard, Cbl has been shown to be a negative regulator of PTK-induced signaling pathway either by directly inhibiting the PTK (Syk) to which it binds (Ota and Samelson, 1997) , or via its interaction with Crk-L (Boussiotis et al., 1997) or with Grb2 (Rellahan et al., 1997) .
Cbl-b, a mammalian homolog of c-Cbl, was recently cloned from human breast cancer cells (Keane et al., 1995) . Cbl-b mRNA is expressed in a variety of normal tissues and cells, and shares several structural characteristics with Cbl including an N-terminal region highly homologous to v-Cbl (79% amino acid identity), a Ring ®nger and C-terminal proline-rich domains. Recently, it was reported that Cbl-b interacts with Vav (Bustelo et al., 1997) . However, unlike the Tyr(P)-Src homology 2 (SH2)-dependent association of Cbl with Vav (Marengere et al., 1997) , Cbl-b binds, via its proline-rich sequences, to the SH3 domain of Vav (Bustelo et al., 1997) . We found that Cbl-b has only one of the two essential 14-3-3-binding serine-rich motifs found in Cbl and, therefore, does not interact with 14-3-3 . Taken together, these ®ndings suggest that Cbl and Cbl-b may have some distinct biological functions. More recently, Cbl-b was reported to undergo tyrosine phosphorylation upon stimulation of FLT3 and interleukin 7 (IL7) receptors in hematopoietic cells . However, at present, the involvement of Cbl-b in intracellular signaling pathways remains unclear.
As a ®rst step towards understanding the involvement of Cbl-b in TCR-mediated signal transduction, we examined the tyrosine phosphorylation of endogenous Cbl-b in Jurkat T cells. We demonstrate that TCR/ CD3 engagement induces rapid tyrosine phosphorylation of endogenous Cbl-b. Both Syk-(Syk/Zap-70) and Src-(Fyn/Lck) family kinases induce the tyrosine phosphorylation of Cbl in COS-1 cells. A Y316 Cblbinding site in Syk is also required for the association with, and for the maximal tyrosine phosphorylation of Cbl-b. In addition, Cbl-b constitutively associates with Grb-2. TCR stimulation induces an enhanced interaction with Crk-L. These results collectively implicate Cbl-b in T cell signaling pathways.
Results

Tyrosine phosphorylation of endogenous Cbl-b in T cells
Although the regulation of tyrosine phosphorylation of Cbl has been extensively studied for the last few years (reviewed in Liu and Altman, 1998) , little is known about Cbl-b. Considering the wide distribution of Cblb mRNA in many dierent tissues and cells, including those of hematopoietic origin (Keane et al., 1995) , we examined if Cbl-b is expressed in T cells and becomes tyrosine phosphorylated upon TCR stimulation. Lysates prepared from unstimulated or anti-CD3-stimulated cells were immunoprecipitated with antiCbl-b antibodies. Four polyclonal anti-Cbl-b antibodies available from commercial sources were used for this purpose. The immunoprecipitates were separated by SDS ± PAGE, transferred onto PVDF membrane, and immunoblotted with an anti-Tyr(P) antibody. As shown in Figure 1a , top panel, all four antibodies immunoprecipitated a *120 kDa Tyr(P)-containing protein from OKT3-stimulated T cells, with the N19 and H-121 showing stronger ability to precipitate this protein than C-20 and H-454. This *120 kDa protein was con®rmed to be Cbl-b protein as a Cbl-b speci®c antibody (OR) (Lavagna-Sevenier et al., 1998) recognized this protein band, when the same membrane was reprobed with this antibody (bottom panel). This result suggests that Cbl-b is endogenously expressed in Jurkat T cells and TCR stimulation induces its tyrosine phosphorylation. To rule out any possibility of cross-reaction of anti-Cbl-b antibodies with endogenous Cbl, cell lysates from unstimulated or OKT3-stimulated Jurkat T cells were immunoprecipitated with N19 or H-121 anti-Cbl-b antibody, or with an anti-Cbl antibody. As shown in Figure 1b , all three antibodies immunoprecipitated *120 kDa Tyr(P)-containing proteins in OKT3-stimulated T cells. When the same membrane was sequentially reprobed with anti-Cbl-b (OR) and anti-Cbl antibodies, Cbl-b protein band was only detected in samples immunoprecipitated with anti-Cbl-b antibodies (N19 or H-121), whereas Cbl protein band was only detected in samples immunoprecipitated with anti-Cbl antibody. This result indicates that the anti-Cbl-b antibodies (N19 and H-121) are speci®c. Therefore, we used either N19 or H-121 (more often N19) anti-Cbl-b antibody for the subsequent immunoprecipitation experiments as indicated, and the OR anti-Cbl-b antibody for immunoblotting, since our preliminary experiments showed neither N19 nor H-121 (nor C-20 or H-454) was suitable for immunoblotting (data not shown). Next, we examined the kinetics of endogenous Cbl-b tyrosine phosphorylation in OKT3-stimulated Jurkat T cells. Cbl-b tyrosine phosphorylation became evident upon 1 min stimulation, and reached the peak at 3 min ( Figure 1c) . It lasted to 10 min point and then showed signi®cant decrease at 15 min point. This rapid tyrosine phosphorylation of Cbl-b correlates with that of endogenous Cbl (Donovan et al., 1994) , suggesting that tyrosine phosphorylations of Cbl-b and Cbl are regulated in a similar mechanism.
Regulation of Cbl-b tyrosine phosphorylation by Sykand Src-family kinases Previously studies have shown that tyrosine phosphorylation of Cbl is coordinately regulated by both Src- and Syk-family kinases Feshchenko et al., 1998; Fournel et al., 1996) . To understand how these kinases aect the tyrosine phosphorylation of Cbl-b, we cotransfected COS-1 cells with plasmid containing Cbl-b cDNA plus empty vector or plasmid containing Syk, Zap-70, Fyn, or Lck cDNA. Cell lysates prepared from these transiently transfected cells were immunoprecipitated with antiCbl-b (N19) antibody. As shown in Figure 2 , no apparent tyrosine phosphorylation of Cbl-b was observed in cells co-transfected with Cbl-b and empty vector. All four tyrosine kinases induced tyrosine phosphorylation of Cbl-b. Of the four kinases, Syk caused the most prominent tyrosine phosphorylation of Cbl-b. The proper expression of respective tyrosine kinases was analysed by immunoblotting the cell lysates with anti-Tyr(P) antibody. Although this experiment could not tell the exact amount of overexpressed tyrosine kinases, it could detect endogenous autophosphorylation and hence the kinase activity of respective kinases. As shown in Figure 2 , bottom panel, Syk and Fyn showed comparable levels of tyrosine phosphorylation, whereas Zap-70 exhibited the least and Lck exhibited the most tyrosine phosphorylation of all four kinases. This result supports the afore-mentioned observation that Syk is a prominent kinase for Cbl-b. The low kinase activity of Zap-70 as observed in this study was consistent with previous observations that Zap-70 is not active in COS-1 cells by comparison with Syk, and that coexpression of a Src kinase (Lck or Fyn) is required for the activation of Zap-70 in these cells (Latour et al., 1996) .
Syk phosphorylates and interacts with Cbl-b
Previous studies have shown that Cbl interacts with Syk . We recently reported that Cbl associates with Syk via a Tyr-316 site of Syk, and that a Y316F mutation in Syk reduced its interaction with and the tyrosine phosphorylation of Cbl (Deckert et al., 1998) Previous studies including our own indicated that the N-terminal region of Cbl is required for the interaction with Syk and Zap-70, and that a loss-offunction mutation in Cbl or its oncogenic mutant 70Z (G306E) disrupts their interaction with Zap-70 Lupher et al., 1996 Lupher et al., , 1997 Zhang et al., 1998) . Next, we examined if Cbl-b interacts with Syk in a similar manner as Cbl/Syk interaction. To this end, we constructed a loss-of-function mutation (G298E) in the N-terminal region of Cbl-b (Cbl-b-N), which corresponds to G306E mutation in Cbl, and cotransfected Jurkat-TAg cells with plasmid containing Cbl-b-N or G298E mutant cDNA plus Syk cDNA plasmid. Lysates prepared from resting or OKT3-stimulated cells were immunoprecipitated with an anti-HA antibody. The immunoprecipitates were analysed with anti-Tyr(P) antibody. As shown in Figure 3c , top panel, a *72 kDa Tyr(P)-containing protein comigrat- lanes 3 and 4) . However, Cbl-b-C showed a basal level of tyrosine phosphorylation (lane 5), which was enhanced upon OKT3-stimulation (lane 6). To ensure that similar amounts of HA-tagged proteins were present among all samples, the same membrane was then stripped, and reprobed with anti-HA antibody. As shown in Figure  5b , all the HA-tagged Cbl-b proteins were detected to a similar degree. This result indicates that the tyrosine phosphorylation sites most likely reside in the Cterminal region of Cbl-b, similar to Cbl .
It is well documented that the proline-rich domain of Cbl interacts with the SH3 domain of Grb2 . Since Cbl-b has proline-rich sequences similar to Cbl, we then mapped the Grb2-binding region in Cbl-b. The same membrane analysed in Figure 5a was stripped, and reincubated with an anti-Grb2 antibody. Both full-length Cbl-b and Cbl-b-C, but not Cbl-b-N, coimmunoprecipitated with Grb2 (Figure 5c ), consistent with the presence of proline-rich sequences in the C-terminal region. Like endogenous Grb2/Cbl-b association (Figure 4 ), no signi®cant dierence was observed between resting and OKT3-stimulated cells in Grb2 interaction with either fulllength Cbl-b or with Cbl-b-C, suggesting that Grb2/ Cbl-b interaction is constitutive.
Mapping of Crk-L-binding region in Cbl-b
The observation of stimulation-dependent Cbl-b/Crk-L association (Figure 4 3 and lanes 8 vs 7) . As a control, the respective proteins in the cell lysates were detected at a similar level (Figure 6b, bottom panel) .
To determine whether the observed in vitro interaction between Cbl-b, or Cbl-b-C, and Crk-L can also occur in vivo, we performed coimmunoprecipitation experiments in cells overexpressing Cbl-b, Cblb-N, or Cbl-b-C using an anti-Crk-L antibody. OKT3-stimulation induced markedly coimmunoprecipitation of Cbl-b with anti-Crk-L (Figure 6c , top panel, lane 2), and no interaction was observed between Crk-L and phorylated residues in Cbl-b. Alternatively, the presence of both tyrosine residues are required for its tyrosine phosphorylation.
To examine whether these mutations aect Crk-L/ Cbl-b interaction, cell lysates similarly prepared as above were incubated with GST-Crk-L, and then analysed with anti-HA antibody. As shown in Figure  7b , top panel, GST-Crk-L bound to Y665F mutant to a slightly lower extent as compared with unmutated 595 ± 982 fragment under OKT3-stimulated conditions (lane 4 vs lane 2). Y709F mutant interacted very weakly with GST-Crk-L under either unstimulated or OKT3-stimulated conditions (lanes 5 and 6). The double mutant (YYFF) showed almost no interaction with GST-Crk-L (lanes 7 and 8). As a control, the same membrane was reprobed with an antibody against C3G, which constitutively associates with Crk-L (Tanaka et al., 1997) . The C3G protein was detected to a similar degree in all the samples (bottom panel).
To further examine the Crk-L-binding site(s) in Cblb in vivo, we performed coimmunoprecipitation experiments in T cells overexpressing the abovementioned wild-type or Tyr-mutated Cbl-b fragment proteins using anti-Crk-L antibody. As shown in Figure 7c Engagement of TCR induces rapid increases in the kinase activity of two family PTKs, the Src (Lck and Fyn) and the Syk (Syk and Zap-70) families (Wange and Samelson, 1996; Weiss and Littman, 1994) . Both Src-and Syk family kinases are implicated in the tyrosine phosphorylation of Cbl, that is supported by the evidence that Cbl directly associates with these upstream kinases (reviewed in Liu and Altman, 1998) . Considering the high amino acids homology between Cbl and Cbl-b, and our present ®ndings that endogenous Cbl-b is tyrosine-phosphorylated in T cells, and that both Syk/Zap-70 and Fyn/Lck induce this event in COS-1 cells, it is conceivable that Cbl-b is tyrosine-phosphorylated by a similar mechanism. In the present study, we tried to focus on the regulation of Cbl-b tyrosine phosphorylation by Syk. Transient expression of Syk induced tyrosine phosphorylation of Cbl-b, even under resting conditions, that was slightly enhanced upon TCR stimulation. This observation is consistent with the notion that Syk carries higher intrinsic kinase activity than Zap-70 in either COS cells or Jurkat T cells (Latour et al., 1996 Williams et al., 1998) . The Syk-mediated tyrosine phosphorylation of Cbl-b is further supported by the evidence that Syk associates with Cbl-b (Figure 3) . Notably, A Syk Y316F mutation, which disrupts its interaction with Cbl , reduced the tyrosine phosphorylation of, and its association with Cbl-b, suggesting that Syk/Cbl-b interaction is required for the maximal tyrosine phosphorylation of Cbl-b. Although we did not directly analyse the eect of Zap-70 on Cbl-b tyrosine phosphorylation and their interaction in T cells, it can be expected that Zap-70 exerts a similar ability as Syk in intact T cells. Indeed, coexpression of Lck or Fyn with Zap-70 in COS-1 cells resulted in stronger tyrosine phosphorylation of Cbl-b than Zap-70 alone (data not shown). Similarly, a Y292 residue in Zap-70, which corresponds to Syk Y316, was recently mapped to be the binding site for Cbl (Lupher et al., 1997) .
The tyrosine phosphorylation of Cbl-b-C observed in transiently transfected Jurkat-TAg cells suggests an alternative N-terminus-independent mechanism for the regulation of Cbl-b tyrosine phosphorylation. This result is consistent with our previous observation in Cbl: the C-terminal portion of Cbl is tyrosine phosphorylated in Jurkat T cells following TCR stimulation . In addition, we previously demonstrated that this alternative mechanism for the tyrosine phosphorylation of Cbl appears to require the presence of Fyn . Thus, we speculate that the tyrosine phosphorylation of Cbl-b in T cells is also coordinately regulated by both Src-and Syk-family kinases. In this regard, it was reported that Cbl-b also interacts with the SH3 domain of Fyn (Keane et al., 1995) . More recently, Cbl-b was reported to undergo tyrosine phosphorylation by stimulation of FLT3 and interleukin-7 receptor in hematolymphoid cells, suggesting that Cbl-b is involved in a large number of PTK-regulated signaling pathways in hematopoietic cells (Lavagna-Sevenier et al., 1998) .
Notably, Zap-70 Y292 was demonstrated to be a negative regulatory site: Y292F mutant exhibits constitutive activation towards NFAT activation (Kong et al., 1996; Zhao and Weiss, 1996) . We recently observed that SykY316F mutant showed higher activity in inducing both basal and TCRstimulated NFAT activation by comparison with wild-type Syk (unpublished results). These observations suggest that by binding to upstream PTKs, such as Syk or Zap-70, Cbl regulates negatively these kinases, thus exerting a negative role in TCR-mediated signaling. In support of this notion are the observations that Cbl directly inhibits the kinase activity of Syk in basophilic cells (Ota and Samelson, 1997) , and that thymocytes from Cbl 7/7 mice showed higher Zap-70 kinase activity that those from normal mice (Murphy et al., 1998) . Since Cbl-b also binds Syk Y316 (and probably Zap-70 Y292) site, it could be speculated that Cbl-b also exerts its biological role by aecting the upstream PTKs. In this regard, we recently demonstrated that an oncogenic Cbl mutant 70Z, which has 17 amino acids deletion near the Ring ®nger, increases both the basal level and ionomycinstimulated NFAT activation (Liu et al., 1997a) . Mutation at a conserved loss-of-function site (G306E) in 70Z disrupts its association with Zap-70 and abolished its eect on NFAT activation , suggesting that by binding to Zap-70, 70Z plays a positive role in TCR-mediated signaling. Therefore, whether Cbl-b has a positive or a negative eect on Syk/Zap-70 needs further investigation.
In addition to the association with upstream Syk kinase, Cbl-b forms molecular complex by constitutive interaction with Grb2 and by an activation-dependent interaction with Crk-L. The Grb2-binding region in Cbl-b was mapped to the proline-rich C-terminal portion, consisting with a recent report that Grb2 SH3 domains are required for its interaction with Cblb (Lavagna-Sevenier et al., 1998) . Previous studies showed that either Y 700 MTP, Y 774 DVP, or both in Cbl mediates the interaction with Crk-L (Andoniou et al., 1996; . We recently demonstrated that Y700/774 double mutant abolished its binding to Crk-L, whereas Y770F or Y774F single mutation showed only slight eects on Crk-L binding , suggesting that both tyrosine residues mediate this association. Although Cbl-b contains an identical YDVP motif, mutation at this site showed only slight eect on Cbl-b/Crk-L interaction. However, a Y709F mutation markedly disrupted its interaction with Crk-L. This eect was speci®c: since both Y655F and Y709F mutations showed similar level of tyrosine phosphorylation, only Y709F mutation had signi®cant reducing eect on Crk-L interaction. This result suggests that Tyr-709 of Cbl-b plays a critical role in mediating Crk-L interaction. The biological signi®cance of the differential usage of Crk-L-binding sites in Cbl and Cbl-b is unclear.
We previously reported that Cbl binds p85 via a YEAM motif of Cbl in an activation-dependent manner (Liu et al., 1997a) . Since the YEAM motif is missing in Cbl-b, the weak, stimulation-independent interaction between Cbl-b and p85 observed in coimmunoprecipitation (Figure 4 ) may represent an indirect association. This notion was supported by the observation that GST-p85 failed to precipitate Cbl-b, whereas GST-p85 associated with Cbl ( Figure 6a ). We reported that mutation at a p85-binding site in oncogenic 70Z results in an enhanced induction of NFAT activation under either basal or ionomycinstimulated conditions by comparison with unmutated 70Z, suggesting that 70Z/PI3-K interaction plays a negative role . The dierence between Cbl and Cbl-b in PI3-K binding provides evidence that these two molecules may have dierent functions.
The functional implication of Grb2/Cbl-b or Crk-L/ Cbl-b interaction is unclear. Crk-L can bind constitutively with C3G via the SH3 domains of Crk-L and the proline-rich domain of C3G (Tanaka et al., 1997) , as also shown in present study (Figure 7b) . A recent study showed that a Cbl-mediated Crk-L-C3G-Rap1 signaling pathway is responsible for the defect in IL2 production in anergic T cells (Boussiotis et al., 1997) . In support of this observation, we recently demonstrated that like mutation at the PI3-K-binding site, mutation of the Crk-L-binding sites (Y700/Y774) in 70Z induces higher NFAT activation by comparison with unmutated 70Z . These data collectively suggest a negative role for Cbl-b mediated by Cbl-b/Crk-L interaction.
Taken together, it can be envisioned that Cbl-b participates in the TCR-mediated signaling through a dual mechanism, one by regulating the upstream PTKs (Syk and Zap-70) to which Cbl-b binds via its Nterminal PTB domain, another by aecting downstream signaling via its C-terminal interaction with Crk-L or Grb2. The high homology between Cbl and Cbl-b suggests that both proteins have a similar biological function. However, the dierences between Cbl-b and Cbl in the interaction with other molecules such as 14-3-3 ) and PI3-K as shown in the present study implicate that these two molecules may exert dierent biological roles, depending on the speci®c signaling pathway and/or the particular cellular context. It remains to be assessed that the relative levels of protein expression of these family members in T cells, which might also have signi®cant impact on their respective role(s) in TCR-mediated signaling transduction. Clearly, additional studies are needed to elucidate the role(s) of Cbl-b and/or Cbl in intracellular signaling pathways. The current ®ndings provide a framework for future studies on the function of Cbl-b in TCR-mediated signal transduction.
